Home/Filings/4/0001104659-20-008837
4//SEC Filing

Einhorn Andrew J. 4

Accession 0001104659-20-008837

CIK 0001739426other

Filed

Jan 29, 7:00 PM ET

Accepted

Jan 30, 5:38 PM ET

Size

5.6 KB

Accession

0001104659-20-008837

Insider Transaction Report

Form 4
Period: 2020-01-28
Einhorn Andrew J.
Chief Financial Officer
Transactions
  • Tax Payment

    Ordinary Shares

    2020-01-28$7.00/sh9,184$64,28895,665 total
Holdings
  • Ordinary Shares

    (indirect: By family limited liability company)
    22,852
Footnotes (1)
  • [F1]The Reporting Person is the sole managing member of the limited liability company and, as a result, may be deemed to beneficially own the ordinary shares held by the limited liability company. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein.

Documents

1 file

Issuer

Osmotica Pharmaceuticals plc

CIK 0001739426

Entity typeother

Related Parties

1
  • filerCIK 0001560685

Filing Metadata

Form type
4
Filed
Jan 29, 7:00 PM ET
Accepted
Jan 30, 5:38 PM ET
Size
5.6 KB